Clinical Trial Update: Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Flutiform, Fluticasone, and Seretide in paediatric patients with moderate to severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)
• Fluticasone (fluticasone propionate)
• Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Asthma | Phase 3 | Status: COMPLETED